Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,305.00    -15.00 (-0.65%)
Bid:
2,300.00
Ask:
2,305.00
Spread: 5.00 (0.217%)
Market Cap: £3.13b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 May 2023 07:00

RNS Number : 6319Z
RIT Capital Partners PLC
17 May 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

17 May 2023

 

Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 April 2023 (with debt at fair value) was 2,367p per £1 ordinary share (31 March 2023: 2,405p). This is after deduction of the first interim dividend of 19p per £1 ordinary share paid on 28 April 2023.

 

April 2023 Highlights

 

Global equity markets were broadly stable in April as Q1 economic indicators and quarterly earnings remained healthy, while overall sentiment was impacted by the prospects for further rate rises and continued concerns around banking system stability. Against this backdrop, we continued to maintain a cautious net quoted equity exposure of around 37%, at the low end of our historical range.

 

· The Quoted Equities book saw healthy performance from Japan and Healthcare, partly offset by weakness in China.

· In our Private Investments book, ~12% of our private funds have reported valuations to 31 March and ~86% are held at 31 December valuations. Our second largest direct private holding, Webull, completed an equity issuance in April at a price above carrying value.

· Our Uncorrelated Strategies showed healthy performance, helped by positive contributions from market neutral strategies and continued momentum in gold.

· The key headwind during the period was currency movements, with Sterling recording gains against major currencies including the Dollar, the Euro and the Yen.

· Our share price benefitted from a narrowing of the discount, with the shares closing the month at a discount to NAV of -15.3%. The Board continued to take advantage of the discount, buying back 1.1 million shares in April. This directly benefits shareholders through the accretive impact to NAV per share.

· The portfolio continues to hold a substantial liquidity balance. As at 30 April, total cash and short-term gilts were approximately £358 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQQLFFXELXBBE
Date   Source Headline
4th Feb 20259:18 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20252:23 pmRNSTotal Voting Rights
31st Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20255:13 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSShare Buyback Management
2nd Jan 20257:00 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSNet Asset Value(s)
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 202411:57 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSNet Asset Value(s)
18th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 202411:20 amRNSComposition of Conflicts Committee
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 202412:14 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.